142 related articles for article (PubMed ID: 32187895)
21. Clinicopathological features of five unusual cases of intraosseous myoepithelial carcinomas, mimicking conventional primary bone tumours, including EWSR1 rearrangement in one case.
Rekhi B; Joshi S; Panchwagh Y; Gulia A; Borges A; Bajpai J; Jambehekar NA; Pant V; Mandholkar M; Byregowda S; Puri A
APMIS; 2016 Apr; 124(4):278-90. PubMed ID: 26768122
[TBL] [Abstract][Full Text] [Related]
22. Role of endoscopic transnasal surgery for skull base chondrosarcoma: a retrospective analysis of 19 cases at a single institution.
Hasegawa H; Shin M; Kondo K; Hanakita S; Mukasa A; Kin T; Saito N
J Neurosurg; 2018 May; 128(5):1438-1447. PubMed ID: 28686110
[TBL] [Abstract][Full Text] [Related]
23. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
[TBL] [Abstract][Full Text] [Related]
24. Chondrosarcoma of the skull base: long-term follow-up.
Brackmann DE; Teufert KB
Otol Neurotol; 2006 Oct; 27(7):981-91. PubMed ID: 17006349
[TBL] [Abstract][Full Text] [Related]
25. Squash Cytology of a Dural-Based High-Grade Chondrosarcoma May Mimic That of Glioblastoma in the Central Nervous System.
Lee S; Kim NR; Chung DH; Yee GT; Cho HY
Acta Cytol; 2015; 59(2):219-24. PubMed ID: 25997403
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathologic features of non-keratinizing carcinoma of nasal cavity and paranasal sinus].
Zhao YH; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):636-41. PubMed ID: 27646894
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathologic features of osteochondroma with malignant transformation].
Zheng L; Zhang HZ; Huang J; Tang J; Liu L; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):609-13. PubMed ID: 20079189
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.
Weber DC; Badiyan S; Malyapa R; Albertini F; Bolsi A; Lomax AJ; Schneider R
Neuro Oncol; 2016 Feb; 18(2):236-43. PubMed ID: 26323608
[TBL] [Abstract][Full Text] [Related]
29. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study.
Holtzman AL; Rotondo RL; Rutenberg MS; Indelicato DJ; Mercado CE; Rao D; Tavanaiepour D; Morris CG; Louis D; Flampouri S; Mendenhall WM
J Neurooncol; 2019 May; 142(3):557-563. PubMed ID: 30827010
[TBL] [Abstract][Full Text] [Related]
30. [Pathology of myxoid bone tumors of the skull base].
Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical and ultrastructural study of skull base chordomas.
Kubota T; Sato K; Kabuto M; Kawano H; Nakagawa T; Arai Y; Tachibana O; Yoshida K; Yamashita J
Noshuyo Byori; 1994; 11(1):23-8. PubMed ID: 7512866
[TBL] [Abstract][Full Text] [Related]
32. [Paraganglioma of urinary bladder: a clinicopathological features analysis of 23 cases].
Fan DG; Wu CL; Huang HJ; Wu L; Chen H; Cai SS; Lin N; Lin SY
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):311-316. PubMed ID: 32268666
[No Abstract] [Full Text] [Related]
33. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
[TBL] [Abstract][Full Text] [Related]
34. Chondroid chordoma: fine-needle aspiration cytology with histopathological, immunohistochemical, and ultrastructural study of two cases.
Moriki T; Takahashi T; Wada M; Ueda S; Ichien M; Miyazaki E
Diagn Cytopathol; 1999 Nov; 21(5):335-9. PubMed ID: 10527481
[TBL] [Abstract][Full Text] [Related]
35. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
36. Low-grade myxoid chondrosarcoma of the temporal bone: differential diagnosis and report of two cases.
Reid CB; Fagan PA; Turner J
Am J Otol; 1994 May; 15(3):419-22. PubMed ID: 8579153
[TBL] [Abstract][Full Text] [Related]
37. Myxoid chondrosarcoma (chordoid sarcoma) of bone: a report of two cases and review of the literature.
Kilpatrick SE; Inwards CY; Fletcher CD; Smith MA; Gitelis S
Cancer; 1997 May; 79(10):1903-10. PubMed ID: 9149016
[TBL] [Abstract][Full Text] [Related]
38. Spinal drop metastasis from grade I skull base chondrosarcoma.
Hall ND; Fabinyi G; Gul SM; Cher L; Leibsch NJ
J Clin Neurosci; 2010 Jan; 17(1):135-7. PubMed ID: 19864142
[TBL] [Abstract][Full Text] [Related]
39. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
[TBL] [Abstract][Full Text] [Related]
40. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma.
Folpe AL; Agoff SN; Willis J; Weiss SW
Am J Surg Pathol; 1999 Sep; 23(9):1059-67. PubMed ID: 10478665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
